Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of an Opioid Sparing Care Pathway for Patients Undergoing Obesity Surgery
NCT03756961Recruiting
- Sponsor
- University of Gothenburg
- Start
- May 2019
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexmedetomidine, esketamine and lidocaine in postoperative pain and obesity (2 arms), sponsored by University of Gothenburg. Primary endpoint: Difference in post-operative pain at 4 hours. Started May 2019; status: recruiting.
02
Drugs
dexmedetomidineesketaminelidocaine
03
Conditions
postoperative painobesity
Beyond the preview
Go deeper on NCT03756961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756961.